TR200800634A2 - Fluvastatin tablet for extended release. - Google Patents

Fluvastatin tablet for extended release.

Info

Publication number
TR200800634A2
TR200800634A2 TR2008/00634A TR200800634A TR200800634A2 TR 200800634 A2 TR200800634 A2 TR 200800634A2 TR 2008/00634 A TR2008/00634 A TR 2008/00634A TR 200800634 A TR200800634 A TR 200800634A TR 200800634 A2 TR200800634 A2 TR 200800634A2
Authority
TR
Turkey
Prior art keywords
extended release
fluvastatin tablet
fluvastatin
tablet
fluvastate
Prior art date
Application number
TR2008/00634A
Other languages
Turkish (tr)
Inventor
Takka Sevgi̇
Çelebi̇ Nevi̇n
Ağabeyoğlu İlbeyi̇
Tirnaksiz Fi̇gen
Deği̇m Tuncer
Deği̇m Zeli̇hagül
Acartürk Füsun
Original Assignee
Takka Sevgi̇
Çelebi̇ Nevi̇n
Ağabeyoğlu İlbeyi̇
Acartürk Füsun
Deği̇m Tuncer
Deği̇m Zeli̇hagül
Tirnaksiz Fi̇gen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takka Sevgi̇, Çelebi̇ Nevi̇n, Ağabeyoğlu İlbeyi̇, Acartürk Füsun, Deği̇m Tuncer, Deği̇m Zeli̇hagül, Tirnaksiz Fi̇gen filed Critical Takka Sevgi̇
Priority to TR2008/00634A priority Critical patent/TR200800634A2/en
Priority to PCT/TR2008/000081 priority patent/WO2009096908A2/en
Publication of TR200800634A2 publication Critical patent/TR200800634A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Mevcut buluş uzatılmış salım sağlayan fluvastatın matris tablete ilişkin olup, özelliği direk basım yöntemi ile hazırlanması ve jel yapıcı ajan olarak en az bir selüloz polimer bileşiği ile yüzey aktif ajan olarak polaksamer içermesidir.The present invention relates to an extended release fluvastate matrix tablet characterized in that it is prepared by direct compression and comprises at least one cellulose polymer compound as a gel-forming agent and polaxamer as a surfactant.

TR2008/00634A 2008-01-30 2008-01-30 Fluvastatin tablet for extended release. TR200800634A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2008/00634A TR200800634A2 (en) 2008-01-30 2008-01-30 Fluvastatin tablet for extended release.
PCT/TR2008/000081 WO2009096908A2 (en) 2008-01-30 2008-07-15 Extended-release fluvastatin tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2008/00634A TR200800634A2 (en) 2008-01-30 2008-01-30 Fluvastatin tablet for extended release.

Publications (1)

Publication Number Publication Date
TR200800634A2 true TR200800634A2 (en) 2009-02-23

Family

ID=39720609

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2008/00634A TR200800634A2 (en) 2008-01-30 2008-01-30 Fluvastatin tablet for extended release.

Country Status (2)

Country Link
TR (1) TR200800634A2 (en)
WO (1) WO2009096908A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100598326B1 (en) * 2004-04-10 2006-07-10 한미약품 주식회사 EXTENDED RELEASE ORAL FORMULATION OF HMG-CoA REDUCTASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF
GR1006879B (en) * 2005-09-14 2010-07-13 "Φαρματεν" Φαρμακευτικη Βιομηχανικη Εμπορικη Α.Ε., Improved pharmaceutical composition containing hmg-coa reductase inhibitor and method for the preperation thereof
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions

Also Published As

Publication number Publication date
WO2009096908A2 (en) 2009-08-06
WO2009096908A3 (en) 2009-10-15

Similar Documents

Publication Publication Date Title
CL2011000423A1 (en) Composition comprising a pd-1 receptor antagonist compound and an enhancer agent; method to increase a t-cell response in a mammal and its use to treat cancer.
TR201910320T4 (en) Culture method for liver organoid, their use and obtaining.
TR201907828T4 (en) AN ANTI-MICROBIAL AGENT WITH A WIDE SPECTRUM
TR201907783T4 (en) Benzosulfonamide derivatives, compositions and their use in the prevention of cancer cell metastasis.
GB2491068A (en) Hydraulically released window mill
MX2009002266A (en) Construction vehicle with rear object detection.
EA201100306A1 (en) CYCLOGEXILAMIDE DERIVATIVES AND THEIR APPLICATION AS ANTAGONISTS OF CRF-1 RECEPTOR
TR201902494T4 (en) Pyrrolobenzodiazepines and their conjugates.
DOP2011000084A (en) USE OF DITIINE-TETRACARBOXIMIDES TO COMBAT FITOPATOGEN FUNGI
WO2012006476A3 (en) Methods and compositions for quantifying exosomes
UY33647A (en) ? AGENTS OF UNION TO CD33 ?.
ECSP10010666A (en) DRONEDARONA FOR THE PREVENTION OF PERMANENT HEADPHONE FIBRILATION
UY33124A (en) AGENTS AND EPITHES LINKED TO WISE
BR112015001414A2 (en) antiderive composition
BR112012024432A2 (en) fast dissolving pharmaceutical composition
EA201201406A1 (en) FUNGICIDAL MIXTURES II, CONTAINING QUINAZOLINS
TR201905456T4 (en) MELT PROCESSED POLYMER COMPOSITION OBTAINED FROM THE LEAVES OF ARECACEAE TREES
PE20142325A1 (en) COMPOSITIONS DERIVED FROM CHITOSANE
FR2969652B1 (en) USE OF IRON PARTICLE DISPERSIONS AS A FUEL ADDITIVE
TR200802713A2 (en) A pharmaceutical formulation based on iron zinc for the treatment of iron deficiency
EA201390449A1 (en) LOW BALANCE
TR200800634A2 (en) Fluvastatin tablet for extended release.
EP2121969A4 (en) Method of detecting equine polysaccharide storage myopathy
PA8852001A1 (en) DERIVATIVES OF LISINA AND ORNITINE MARKED WITH RADIOISOTOPES, ITS USE AND PROCESSES FOR THEIR PREPARATION
TR201109158A2 (en) Easily soluble pharmaceutical composition containing eplerenone.